Twitter-Delivered CME/CE on
Chronic Kidney Disease from @ckd_ce
The need for consistent updates and agile content is imperative for today’s clinician to remain current on the continuum of scientific data. This is particularly important in the care of patients with or at risk for CKD, as this has become a multidisciplinary and interprofessional focus. Kidney health is now linked not only pathophysiologically but also by treatment strategies that target diverse cardiovascular outcomes as well as renal health. These issues are subject to frequent pivotal trial publications, guidelines updates, FDA action, and outcomes assessments.
Our Tweetorials
Your new source for free CE/CME via Twitter!
Each program provides 0.5hr – 1.0hr credit for physicians, pharmacists, and nurses.
Longer-Term Clinical Outcomes of Transplantation of HCV-RNA+ Donor Kidneys Into Hepatitis C Virus-Negative Recipients
2) Our returning guest author is @happiedocOur topic for 🆓 CE/#CME: Longer-Term Clinical Outcomes From the #THINKER and #EXPANDER Trials of...
TRPC6 Inhibitor Study Design for FSGS
1b) Our topic for🆓CE/#CME : #FSGS and BI 764198, a selective oral #TRPC6 inhibitor. You can learn more about FSGS here: https://t.co/dcHRskjRwL by...
The KFRE and How It Is Used
1b) Faculty disclosures are listed at https://t.co/PHlIppl6Yw. Please also check out, for more 🆓credit, the #blogposts edited by @sophia_kidney at...
ASN-IgAN Highlights
2) @IgAN_JBarratt attended #KidneyWk 2023 and collected the best #IgAN highlights to share with our followers and learners here on @ckd_ce, your...
Clinical Trial Update & Potential Clinical Applications for HIF-PHI Therapeutics for Patients on Hemodialysis for CKD
1b) Our expert guest faculty is #nephrologist @DrBobPro1 of @waynemedicine.#nephtwitter @MedTweetorials @ISNkidneycare @goKDIGO @KIRepors. Earn more...
Obesity and CKD: A High-Risk Combination
1b) Our topic for🆓CE/#CME : #Obesity and #CKD!#MedTwitter #nephtwitter @ISNkidneycare #FOAMedFollow this 🧵 for 0.5hr 🆓CE/#CME, and follow @ckd_ce...
Epidemiology of CKD-Associated Anemia
1b) Name familiar? It oughta be! @sophia_kidney works with us on tweetorials for @KIReports and on #accredited blogposts that you'll find only...
Effect of Belimumab on Preventing de novo Renal Lupus Flares
1b) Our topic for🆓CE/#CME : #belimumab and prevention of de novo #renal_flare.#MedTwitter #nephtwitter @ISNkidneycare #lupus @MedTweetorials...
IgAN 101
2a) Statement of accreditation & faculty disclosures are listed at https://t.co/PHlIppl6Yw. Please also check out, for more 🆓credit, the...
Nirogacestat and Hypophosphatemia
1b) This is part of a foundational 🫘 #MedEd #accredited series hosted by core @ckd_ce faculty @sophia_kidney. See prior #tweetorials, still...
@CKD_CE on Twitter
Your only source for ACCREDITED SoMe-delivered
serialized professional cardiometabolic education. Physicians, nurses, pharmacists–come one, come all!
On Twitter at @ckd_ce, we present a series of tweetorials, Twitter-delivered case studies, and Twitter Journal Clubs, each accredited for 0.5hr – 1.0hr CE/CME. Programs are presented by expert faculty in engaging and fully interactive format. Our unique program harnesses the reach, up-to-the-minute currency, and accessibility of social media to deliver a constant flow of accredited, interactive, expert-delivered educational programs to a multidisciplinary and interprofessional audience of engaged clinicians.